Part of the research suite — sequenced to land before the 2026-09-30 pooled review (#427, discussion #359).
What
Per-rule-family significance testing on the cached candles: is this family's measured edge distinguishable from zero at the fee actually paid? It sits beside PBO/CSCV (keel/research/cscv.py), the DCA benchmark, and Monte Carlo resampling (#441) — #441 asks "is the equity curve an outlier?", this asks "is the edge real at all?"
Framing (non-negotiable)
Report-only evidence for the promotion gate. The honest result stands: no shipped family is net positive at the 120 bp taker fee, and inside the fee-free allowance the reconstruction sits at break-even (14.9% win vs 14.88% required). This tool must be able to say "no" — that is its job.
Acceptance
Part of the research suite — sequenced to land before the 2026-09-30 pooled review (#427, discussion #359).
What
Per-rule-family significance testing on the cached candles: is this family's measured edge distinguishable from zero at the fee actually paid? It sits beside PBO/CSCV (
keel/research/cscv.py), the DCA benchmark, and Monte Carlo resampling (#441) — #441 asks "is the equity curve an outlier?", this asks "is the edge real at all?"Framing (non-negotiable)
Report-only evidence for the promotion gate. The honest result stands: no shipped family is net positive at the 120 bp taker fee, and inside the fee-free allowance the reconstruction sits at break-even (14.9% win vs 14.88% required). This tool must be able to say "no" — that is its job.
Acceptance